PhD offer: EMERALD – ElectroMagnetic imaging for a novel genERation of medicAL Devices


This PhD position is part of the Marie Skłodowska-Curie Innovative Training Network “EMERALD – ElectroMagnetic imaging for a novel genERation of medicAL Devices”, funded by the European Union’s Horizon 2020 Research and Innovation Program.

EMERALD is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to form a cohort of highly-skilled researchers capable of accelerating the translation of this technology “from research bench to patient bedside”. EM imaging technology involves the illumination of the portion of the body under investigation with low-power non-ionizing EM waves in the microwave spectrum and the use of the resultant backscattered signals to generate images of the internal structure of the body.

The objective pursued by EMERALD is to accelerate translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD will establish a group of 13 outstanding early stage researchers (ESRs) who will be the European leaders in this field, through a unique scientific and training program. The EMERALD consortium involves academic institutions, industrial partners, hospitals and university medical centers.

The EMERALD trained researchers will drive the future developments of EM imaging technology, thanks to the targeted skills they will attain, and their established connections with clinicians and stakeholders.


The main research topic of the offered PhD position, available at  will be the design and realization of breast and head phantoms adapted to the geometry of the devices developed in the framework of the EMERALD project and their use for the development of microwave imaging algorithms. The main objectives of the planned research activities will be:

  • Design and production of 3-D printed breast and head phantoms;
  • Production and dielectric characterization of mixtures that mimic different biological tissues in the microwave frequency range;
  • Computation of the electromagnetic field inside the phantom with and without tumor or infarcted tissue mimicking anomaly;
  • Extension of the existing microwave imaging algorithms from the 2D case to the 3D case;
  • Use of the phantoms STL (STereoLithography) files to include a priori information in the microwave imaging algorithms.

This work will include a close collaboration with clinicians involved in the project, particularly those from Lariboisière University Hospital, in France.

More informations: